-+ 0.00%
-+ 0.00%
-+ 0.00%

Invo Fertility Q1 FY26 net loss widens to $5.5 million; revenue rises 23% to $2 million

PUBT·06/22/2026 13:02:15
Listen to the news
Invo Fertility Q1 FY26 net loss widens to $5.5 million; revenue rises 23% to $2 million
  • Invo Fertility posted Q1 2026 revenue of $2.02 million, up 23% year over year.
  • Net loss from continuing operations widened to $5.5 million, including a $3.8 million non-cash loss tied to warrant fair-value changes.
  • Cash climbed to $4.9 million at March 31, 2026, up from $2.1 million at year-end 2025.
  • All Series C-2 Preferred Stock was converted or retired, eliminating warrant liabilities; stockholders’ equity more than doubled to $15 million.
  • The clinic platform expanded with the February acquisition of Family Beginnings, adding a fourth U.S. fertility clinic.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606220900PRIMZONEFULLFEED9750239) on June 22, 2026, and is solely responsible for the information contained therein.